Congressionally Directed Medical Research Programs -- Peer Reviewed Alzheimer’s Disease Research Program -- Innovation in Care and Support Award

Funding Agency:
Department of Defense

The intent of the FY21 PRARP InCASA is to support innovative and impactful research that improves the quality of life and care for individuals, families, and care providers living with AD/ADRD. The proposed work should innovatively challenge existing research paradigms or exhibit high levels of creativity within the context of the PRARP’s mission and vision. This can include innovations and research for symptom reduction (e.g., cognitive, behavioral, function, mood), resiliency factors, increasing or maintaining independence, and support for families and care providers. The application should also demonstrate the study team’s experience in both military risk factor-related research and AD/ADRD as suited to the proposed work. Given the patient-centered intent of the FY21 PRARP InCASA, animal research is prohibited. The research innovation and impact for the FY21 PRARP InCASA are expected to benefit the military, Veteran, and civilian communities. FY21 PRARP InCASA applications must be innovation- and impact-based.

Deadlines:

  • REQUIRED Pre-application Submission Deadline:  June 14, 2021
  • Full Application Submission Deadline:  July 21, 2021

Agency Website

Areas of Interest

The Overarching Challenges below are specific to the FY21 PRARP InCASA. Applicants to the FY21 PRARP InCASA must address and select one of the Overarching Challenges below:

  • Paucity of Clinical Studies: The paucity of clinical studies to examine the interrelationship between military service-related risk factors and subsequent AD/ADRD
  • Quality of Life: The need for technologies, assessments, interventions, or devices to benefit individuals, especially Service Members and Veterans, living with symptoms of AD/ADRD
  • Family and Care Support: The need for technologies, assessments, interventions, or devices that enhance the lives of those providing care and families of individuals, especially Service Members and Veterans, living with the symptoms of AD/ADRD

Eligibility Requirements

Funding Level I: The named PI must be at least at the postdoctoral level (e.g., research associate, fellow, medical resident, or equivalent) but below the level of assistant professor (or equivalent) at the time of the application submission deadline.

Funding Level II: The named PI must be an independent investigator at or above the level of assistant professor (or equivalent) at the time of the application submission deadline.

Amount Description

For Funding Level I: The anticipated direct costs budgeted for the entire period of performance for an FY21 PRARP InCASA will not exceed $225,000. Refer to Section II.D.5, Funding Restrictions, for detailed funding information.

For Funding Level II: The anticipated direct costs budgeted for the entire period of performance for an FY21 PRARP InCASA will not exceed $500,000. Refer to Section II.D.5, Funding Restrictions, for detailed funding information.

Funding Type

Grant

Eligibility

Faculty
Junior Faculty
Medical Fellow/Resident
Post Doctoral Fellows

Category

Engineering and Physical Sciences
Environmental & Life Sciences
Interdisciplinary
Medical
Medical - Basic Science
Medical - Clinical Science
Medical - Translational

External Deadline

June 14, 2021